TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Neurotrauma Research Sweden Nrs AB
Closing information (x1000 EUR)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
43
|
42
|
43 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-18
|
-11
|
-16 |
| EBITDA |
-16
|
-9
|
-14 |
| Total assets |
644
|
618
|
660 |
| Current assets |
11
|
10
|
31 |
| Current liabilities |
49
|
27
|
19 |
| Equity capital |
595
|
590
|
642 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
92.4%
|
95.5%
|
97.3% |
| Turnover per employee |
43
|
42
|
43 |
| Profit as a percentage of turnover |
-41.9%
|
-26.2%
|
-37.2% |
| Return on assets (ROA) |
-2.8%
|
-1.8%
|
-2.4% |
| Current ratio |
22.4%
|
37.0%
|
163.2% |
| Return on equity (ROE) |
-3.0%
|
-1.9%
|
-2.5% |
| Change turnover |
-1
|
1
|
-17 |
| Change turnover % |
-2%
|
1%
|
-29% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.